TCL Archive Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia July 26, 2002
TCL Archive NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms February 8, 1980
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program April 17, 1981
